Blinatumomab Intravenous and Dihydroergotamine injection
Determining the interaction of Blinatumomab Intravenous and Dihydroergotamine injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: blinatumomab
Brand name: Blincyto
Synonyms: Blinatumomab
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Blinatumomab Intravenous-Dihydroergotamine Mesylate
- Blinatumomab Intravenous-Dihydroergotamine nasal
- Blinatumomab Intravenous-Dihydroergotamine Nasal Spray
- Blinatumomab Intravenous-Dilacor XR
- Blinatumomab Intravenous-Dilantin
- Blinatumomab Intravenous-Dilantin Infatabs
- Dihydroergotamine injection-Blincyto
- Dihydroergotamine injection-Blisovi 24 Fe
- Dihydroergotamine injection-Blisovi 24 FE birth control
- Dihydroergotamine injection-Blisovi Fe 1.5/30
- Dihydroergotamine injection-Blisovi Fe 1/20
- Dihydroergotamine injection-Blocadren